These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17173250)

  • 1. Relationship of chronic kidney disease to cardiovascular death and myocardial infarction following coronary stenting.
    Charytan DM; Kuntz RE; Chhabra A; Cutlip DE
    J Nephrol; 2006; 19(6):764-70. PubMed ID: 17173250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up.
    Marcucci R; Gori AM; Paniccia R; Giusti B; Valente S; Giglioli C; Buonamici P; Antoniucci D; Abbate R; Gensini GF
    Circulation; 2009 Jan; 119(2):237-42. PubMed ID: 19118249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term cardiovascular risk of nonsteroidal anti-inflammatory drug use according to time passed after first-time myocardial infarction: a nationwide cohort study.
    Olsen AM; Fosbøl EL; Lindhardsen J; Folke F; Charlot M; Selmer C; Bjerring Olesen J; Lamberts M; Ruwald MH; Køber L; Hansen PR; Torp-Pedersen C; Gislason GH
    Circulation; 2012 Oct; 126(16):1955-63. PubMed ID: 22965337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for non-fatal myocardial infarction and cardiac death in incident dialysis patients.
    Trivedi H; Xiang Q; Klein JP
    Nephrol Dial Transplant; 2009 Jan; 24(1):258-66. PubMed ID: 18682489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study.
    Tokmakova MP; Skali H; Kenchaiah S; Braunwald E; Rouleau JL; Packer M; Chertow GM; Moyé LA; Pfeffer MA; Solomon SD
    Circulation; 2004 Dec; 110(24):3667-73. PubMed ID: 15569840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of target lesion revascularization after coronary stenting in patients with and without chronic kidney disease.
    Charytan D; Forman JP; Cutlip DE
    Nephrol Dial Transplant; 2007 Sep; 22(9):2578-85. PubMed ID: 17517798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.
    Park DW; Kim YH; Yun SC; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Kim JJ; Choo SJ; Chung CH; Lee JW; Park SW; Park SJ
    J Am Coll Cardiol; 2010 Oct; 56(17):1366-75. PubMed ID: 20946993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction.
    Lambert ND; Sacrinty MT; Ketch TR; Turner SJ; Santos RM; Daniel KR; Applegate RJ; Kutcher MA; Sane DC
    Am Heart J; 2009 Apr; 157(4):688-94. PubMed ID: 19332197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II, ICTUS, and RITA-3 trials (FIR).
    Damman P; Wallentin L; Fox KA; Windhausen F; Hirsch A; Clayton T; Pocock SJ; Lagerqvist B; Tijssen JG; de Winter RJ
    Circulation; 2012 Jan; 125(4):568-76. PubMed ID: 22199015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wasting and sudden cardiac death in hemodialysis patients: a post hoc analysis of 4D (Die Deutsche Diabetes Dialyse Studie).
    Drechsler C; Grootendorst DC; Pilz S; Tomaschitz A; Krane V; Dekker F; März W; Ritz E; Wanner C
    Am J Kidney Dis; 2011 Oct; 58(4):599-607. PubMed ID: 21820222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can the optimal type of stent be predicted based on clinical risk factors? A subgroup analysis of the randomized BASKET-PROVE trial.
    Vassalli G; Klersy C; De Servi S; Galatius S; Erne P; Eberli F; Rickli H; Hornig B; Bertel O; Bonetti P; Moccetti T; Kaiser C; Pfisterer M; Pedrazzini G;
    Am Heart J; 2016 Mar; 173():1-7. PubMed ID: 26920590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of coronary artery stenting outcomes in the eras before and after the introduction of drug-eluting stents.
    Hannan EL; Racz M; Holmes DR; Walford G; Sharma S; Katz S; Jones RH; King SB
    Circulation; 2008 Apr; 117(16):2071-8. PubMed ID: 18391112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
    Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
    Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization.
    Das P; Moliterno DJ; Charnigo R; Mukherjee D; Steinhubl SR; Sneed JD; Booth DC; Ziada KM
    J Invasive Cardiol; 2006 Sep; 18(9):405-8. PubMed ID: 16954577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of death or myocardial infarction by exercise single photon emission computed tomography perfusion scintigraphy in patients who have had recent coronary artery stenting.
    Rajagopal V; Gurm HS; Brunken RC; Pothier CE; Bhatt DL; Lauer MS
    Am Heart J; 2005 Mar; 149(3):534-40. PubMed ID: 15864244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High on-treatment platelet reactivity by more than one agonist predicts 12-month follow-up cardiovascular death and non-fatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting.
    Marcucci R; Gori AM; Paniccia R; Giusti B; Valente S; Giglioli C; Buonamici P; Antoniucci D; Abbate R; Gensini GF
    Thromb Haemost; 2010 Aug; 104(2):279-86. PubMed ID: 20508896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein and the risk of stent thrombosis and cardiovascular events after drug-eluting stent implantation.
    Park DW; Yun SC; Lee JY; Kim WJ; Kang SJ; Lee SW; Kim YH; Lee CW; Kim JJ; Park SW; Park SJ
    Circulation; 2009 Nov; 120(20):1987-95. PubMed ID: 19884467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year clinical outcomes in patients with chronic renal failure treated by percutaneous coronary intervention with drug-eluting stent.
    Barthelemy O; Helft G; Silvain J; Bellemain-Appaix A; Beygui F; Choussat R; Berman E; Collet JP; Montalescot G; Metzger JP; Le Feuvre C
    Arch Cardiovasc Dis; 2011 Dec; 104(12):604-10. PubMed ID: 22152512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of renal failure on the risk of myocardial infarction and death.
    Beddhu S; Allen-Brady K; Cheung AK; Horne BD; Bair T; Muhlestein JB; Anderson JL
    Kidney Int; 2002 Nov; 62(5):1776-83. PubMed ID: 12371979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population.
    Meisinger C; Döring A; Löwel H;
    Eur Heart J; 2006 May; 27(10):1245-50. PubMed ID: 16611670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.